Rationale and Comments

Pap testing of the top of the vagina in women treated for endometrial cancer does not improve detection of local recurrence. False-positive Pap smears in this group can lead to unnecessary procedures such as colposcopy and biopsy.

Sponsoring Organizations

• Society of Gynecologic Oncology

Sources

• Society of Gynecologic Oncology guidelines

Disciplines

• Gynecologic
• Oncologic

References

• Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204:466-78.
  
• Salani R, Nagel CI, Drennen E, Bristow RE. Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol. 2011;123:205-7.
  
• Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL II. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol. 2006;103:709-13.